Dl-3-n-butylphthalide attenuates cerebral ischemia/reperfusion injury in mice through AMPK-mediated mitochondrial fusion
Frontiers in Pharmacology · 22.02.2024 · 15
DOI: 10.3389/fphar.2024.1357953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.02.2024. Verfasst von Ting Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Institute of Neuroregeneration & Neurorehabilitation, School of Basic Medicine, Qingdao University, Qingdao, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
NBP is a compound isolated from celery seeds, which was approved by the National Medical Products Administration in 2002 for clinical treatment of ischemic stroke. However, in brain ischemia/reperfusion (I/R) injury, the related research on mitochondrial dynamics and its mechanism of action of NBP still need to be further studied. The aim of this study was to assess NBP on cerebral pathology in ischemic stroke in vivo , with a specific focus on the molecular mechanisms of how NBP promotes mitochondrial fusion.
Methods
Male C57BL/6 mice were utilized in this study and were subjected to middle cerebral artery occlusion/reperfusion (MCAO/R). Pre-ischemia, NBP was administered through intraperitoneal (i.p.) injection for 7 days.
Results
Our findings demonstrated that NBP effectively reduced infarct volume, improved neurological dysfunction, enhanced cerebral blood flow, and promoted mitochondrial fusion in mice subjected to MCAO/R. More importantly, the pro-fusion effects of NBP were found to be linked to the activation of AMPK/Mfn1 pathway, and with the activation of neurological function, which was partially eliminated by inhibitors of AMPK.
Discussion
Our results revealed that NBP is a novel mitochondrial fusion promoter in protecting against ischemic stroke through the AMPK-mediated Mfn1. These findings contribute to the understanding of novel mechanisms involved in the protection of neurological function following NBP treatment for ischemic stroke.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathophysiology, Institute of Neuroregeneration & Neurorehabilitation, School of Basic Medicine, Qingdao University, Qingdao, China.
- Department of Rehabilitation Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zitieren
APA
Zhu, T., Dong, S., Qin, N., Liu, R., Shi, L., & Wan, Q. (2024). Dl-3-n-butylphthalide attenuates cerebral ischemia/reperfusion injury in mice through AMPK-mediated mitochondrial fusion. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1357953
Vancouver
Zhu T, Dong S, Qin N, Liu R, Shi L, Wan Q. Dl-3-n-butylphthalide attenuates cerebral ischemia/reperfusion injury in mice through AMPK-mediated mitochondrial fusion. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1357953
BibTeX
@article{Zhu2024,
author = {Zhu, Ting and Dong, Shanshan and Qin, Na and Liu, Rujuan and Shi, Liuliu and Wan, Qi},
title = {Dl-3-n-butylphthalide attenuates cerebral ischemia/reperfusion injury in mice through AMPK-mediated mitochondrial fusion},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1357953}
}
EUVIMED